This report covers the ADA conference “Research Symposium on the Novel Roles of GI Hormones in Energy Homeostasis, Obesity, and Diabetes”. This ADA conference, sponsored by Amylin Pharmaceuticals, Eli Lilly and Company, Novartis Pharmaceuticals Corporation, and Novo Nordisk Pharmaceuticals, took place in Long Beach, CA, December 9-12, 2003. Approximately 150 doctors, scientists, and industry participants gathered at this series of sessions to discuss the role of GI hormones in diabetes, obesity, and energy homeostasis.
The report covers:
- GI Hormones in Glucose Regulation and GI Hormones in
Diabetes Pathogenesis and Treatments
- GLP-1 overview
- Other treatments involving stem cells and islet growth and differentiation
- The incretin effect
- GI Hormones in Food Intake, Body Weight Regulation, and in Obesity Pathogenesis and Treatment
- Obesity research, including such areas as food intake and body weight regulation
- PYY
- Ghrelin
- Leptin
- Insulin
- Gastric surgery
- Regulation of GI Hormones and GI Function
- DPPIV
- GLP-1: how nutrients are stimulated at the cellular level
- Neurotensin and bombesin
Ordering
Ordering is available online or by calling 415 241 9500.
- Report format: Available electronically in PDF format.
- Pricing: $495
- Please enquire for small company discounts and corporate license fees
- Payment Options:
- By check (Please contact info@closeconcerns.com for address)
- Major credit card (via Paypal) -
please click on the button: